Essential fatty acids and their metabolites in the context of hypertension

This publication has 33 references indexed in Scilit:

• Reactive Oxygen Species and Cyclooxygenase 2-Derived Thromboxane A2 Reduce Angiotensin II Type 2 Receptor Vasorelaxation in Diabetic Rat Resistance Arteries
  Hypertension, 2010
• Interaction(s) of Polyunsaturated Fatty Acids With Dietary Protein and Its Relationship to the Pathogenesis of Hypertension
  American Journal of Hypertension, 2010
• Induction of Hypertension and Peripheral Inflammation by Reduction of Extracellular Superoxide Dismutase in the Central Nervous System
  Hypertension, 2010
• Omega 6 to omega 3 fatty acid imbalance early in life leads to persistent reductions in DHA levels in glycerophospholipids in rat hypothalamus even after long-term omega 3 fatty acid repletion
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2006
• Dietary Approaches to Prevent and Treat Hypertension
  Hypertension, 2006
• Perinatal omega-3 fatty acid deficiency affects blood pressure later in life
  Nature Medicine, 2001
• Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidases
  Cardiovascular Research, 1999
• Effects of n-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension
  Annals of Internal Medicine, 1995
• Does superoxide underlie the pathogenesis of hypertension?
  Proceedings of the National Academy of Sciences, 1991
• Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 1990